Purpose— Our goal is to provide an overview of the current evidence about components of the evaluation and treatment of adults with acute ischemic stroke. The intended audience is physicians and other ...

Extensive evidence indicates that extracellular matrix (ECM)/integrin receptor signaling is also an important regulator of myocardial hypertrophy. Upregulation of collagen III, fibronectin, ...

Heart failure with preserved left ventricular (LV) ejection fraction (EF) is frequently referred to as diastolic heart failure (DHF) in contrast to systolic heart failure, which is characterized by HF ...

Although I agree with the authors that their tDi techniques were sensitive in detecting both systolic and diastolic abnormalities in function, I do not agree with their statement that “conventional ...

BACKGROUND: While mechanical thrombectomy (MT) is proven to be lifesaving and disability sparing, there remains a disparity in its access in low- to middle-income countries. We hypothesized that ...

Methods and Results— We conducted a case-control study nested in the Cardiovascular Health Study. We identified 214 cases of fatal IHD (fatal myocardial infarction and coronary heart disease death) ...

The updated guidelines for managing aSAH emphasize the importance of personalized treatment strategies that consider the unique characteristics of each aneurysm. 1 Extensive research, exemplified by ...

imageWe analyzed carotid revascularizations in the Vascular Quality Initiative, a national clinical registry. Patients were linked to Medicare claims to identify long‐term outcomes. Our study cohort ...

Methods and Results— Eight hundred consecutive patients scheduled for elective PCI by femoral approach were randomized to same-day discharge or overnight hospital stay. Four hours after PCI, patients ...

Abstract Background— BAY 41-2272 is a recently introduced novel orally available agent that directly stimulates soluble guanylate cyclase (sGC) and sensitizes it to its physiological stimulator, ...

Methods and Results— A total of 418 subjects with type 2 diabetes were randomly assigned to 200 mg micronized fenofibrate daily or placebo. The mean follow-up time was 39.6 months. LDL peak particle ...

Home Circulation Vol. 105, No. 23 Impact of Different Platelet Glycoprotein IIb/IIIa Receptor Inhibitors Among Diabetic Patients Undergoing Percutaneous Coronary Intervention Free AccessResearch ...